1 July 2006
Identifying drug metabolites is key to drug discovery because the metabolites could be potentially toxic or could be more efficacious than the drug itself. Applied Biosystems/MDS SCIEX's metabolite ID solution enables drug discovery scientists to examine thousands of drug candidates and quickly determine those that fail to meet the requirements for further development.
More than 100 pharmaceutical scientists from 35 companies worldwide provided input and feedback for the development of the LightSight Software
This new pharmaceutical application can be employed with the 4000 Q TRAP mass spectrometer, as well as other triple quadrupole and hybrid linear ion mass spectrometers from Applied Biosystems/MDS SCIEX. The application is designed to be workflow-based for the metabolite ID lab, allowing for a larger number of experiments to be performed without an increase in resources or training.